DCGP: Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes Mellitus

Sponsor
Research Unit Of General Practice, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT01074762
Collaborator
(none)
1,470
1
1
83.1
17.7

Study Details

Study Description

Brief Summary

The aims of a concluding 14-year follow-up study are:
  • To investigate what long-term effect the project model for structured, personalized diabetes care has on 1) the patients' mortality and development of diabetic complications, 2) the patients' use of services from the primary and secondary sector,
  1. the patients' self-rated health and motivation, and 4) the doctor-patient relationship.
Condition or Disease Intervention/Treatment Phase
  • Behavioral: Structured personal care
N/A

Detailed Description

Type 2 diabetes (T2DM) is an increasingly common illness that is linked to considerable excessive mortality. There are many indications that treatment of raised blood pressure and blood glucose as well as dyslipidaemia can postpone the development of diabetic complications. Treatment of T2DM is primarily done in general practice, where the results are not satisfactory. The purpose of the project is to create a basis so the existing research-based knowledge can be used to improve the quality of diabetes care in general practice.

The answer will be based on the information from 1,428 newly diagnosed diabetic patients aged 40 or over who were followed since 1989 in a randomised trial among more than 600 general practitioners. The intervention, which ended at the beginning of 1996, provided optimum conditions for follow-up, doctor-patient communication and treatment, among other ways by training the doctors, producing clinical guidelines and setting individual treatment goals. In the project, the general practitioner is seen as the coordinator of the whole health system's prophylactic efforts in relation to the individual diabetic patient.

The aims of a concluding 14-year follow-up are:
  • To investigate what long-term effect the project model for structured, personalized diabetes care has on 1) the patients' mortality and development of diabetic complications, 2) the patients' use of services from the primary and secondary sector,
  1. the patients' self-rated health and motivation, and 4) the doctor-patient relationship.

Study Design

Study Type:
Interventional
Actual Enrollment :
1470 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
The Diabetes Care in General Practice Study: Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes Mellitus
Study Start Date :
Mar 1, 1989
Actual Primary Completion Date :
Feb 1, 1996
Actual Study Completion Date :
Feb 1, 1996

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Routine general practice care

In the comparison group, doctors were free to choose any treatment and change it over time. The study coordinating centre did not contact comparison practices after the end of recruitment (late 1991) until 1995.

Behavioral: Structured personal care
General practitioners (GPs) were recommended to perform regular follow up every three months and an annual screening for diabetic complications. The GP was requested to define, together with the patient, the best possible goals for blood glucose concentration, glycated haemoglobin (HbA1c), diastolic blood pressure, and lipids within three predefined categories. At each quarterly consultation, the GP was asked to compare the achievements with the goal and consider changing either goal or treatment accordingly. The doctors received annual descriptive feedback reports on individual patients. The GPs were introduced to possible solutions to therapeutic problems through clinical guidelines supported by an annual half day seminar. Patient leaflets were produced for the doctor to hand out.

Outcome Measures

Primary Outcome Measures

  1. Mortality [From diabetes diagnosis until median14 year after study start]

    The vital status of all patients was certified on the 31 January, 2006 through The Danish Civil Registration System (www.cpr.dk) which includes complete and continuously updated information on all Danish residents on vital status.

  2. Diabetic retinopathy [at 6 year and 14 year after study start]

    Incidence of diabetic retinopathy

  3. Urinary albumin concentration [at 6 year and 14 year after study start]

    Incidence of urinary albumin concentration > 15 mg/l

  4. Myocardial infarction [From diabetes diagnosis until median14 year after study start]

    Incidence of myocardial infarction. The national hospital discharge registry provided information on hospital admissions for myocardial infarction, stroke, and amputation from diagnosis until December 31, 2005.

  5. Stroke [From diabetes diagnosis until median14 year after study start]

    Incidence of stroke. The national hospital discharge registry provided information on hospital admissions for myocardial infarction, stroke, and amputation from diagnosis until December 31, 2005.

Secondary Outcome Measures

  1. New peripheral neuropathy [at 6 year and 14 year after study start]

  2. New angina pectoris [at 6 year and 14 year after study start]

  3. New intermittent claudication [at 6 year and 14 year after study start]

  4. Amputation [From diabetes diagnosis until median14 year after study start]

    Incidence of amputation. The national hospital discharge registry provided information on hospital admissions for myocardial infarction, stroke, and amputation from diagnosis until December 31, 2005.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all patients aged 40 or older with newly diagnosed diabetes between 1 March 1989 and 28 February 1991 based on hyperglycaemic symptoms or raised blood glucose values measured in general practice
Exclusion Criteria:
  • threatening somatic disease, severe mental illness, or unwillingness to participate. For our analysis, we also excluded non-white patients and patients whose diagnosis was not established by a blood glucose measurement at a major laboratory within 500 days after diagnosis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Research Unit for General Practice in Copenhagen, Centre for Health and Community, Ă˜ster Farimagsgade 5 Copenhagen Denmark DK-1014

Sponsors and Collaborators

  • Research Unit Of General Practice, Copenhagen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01074762
Other Study ID Numbers:
  • DCGP1989
First Posted:
Feb 24, 2010
Last Update Posted:
Feb 24, 2010
Last Verified:
Jul 1, 2003

Study Results

No Results Posted as of Feb 24, 2010